TiGenix Licenses to Takeda Ex-US Rights for Stem Cell Treatment – Genetic Engineering & Biotechnology News (blog)
European Pharmaceutical Review |
TiGenix Licenses to Takeda Ex-US Rights for Stem Cell Treatment
Genetic Engineering & Biotechnology News (blog) TiGenix has sold to Takeda ex-U.S. rights to its stem cell treatment Cx601 for complex perianal fistulas in patients with Crohn’s disease—an up-to-€390 million ($435 million)-plus deal reflecting what the Belgian biotech called a shift of resources … TiGenix reconfirms its strategic focus on its allogeneic stem cell platformsYahoo Finance Takeda inks another biotech pact as it pays $400M+ to TiGenixFierceBiotech |
MinnPost |
Hundreds of US clinics promote unproven stem cell therapies, U of M researcher says
MinnPost Only a few stem cell therapies have been shown through clinical research to be safe and effective for treating medical conditions, mostly cancer and blood and immune disorders. Yet, that hasn’t stopped a growing number of clinics across the United … Global Hematopoietic Stem Cell Transplantation Market Size, Share, Growth, Opportunities And Forecast to 2022 …The Republic of East Vancouver Global Stem Cells Market 2016- Hybrid Organ Gmbh, Intellicell Biosciences Inc., International Stem Cell Corp …OZ Guide – Global Market Research News by Market.biz (press release) |
MedCity News |
Morning Read: Unapproved stem cell tests abound, an artificial pancreas on the horizon
MedCity News More than 300 companies are selling unapproved stem cell tests and procedures in the U.S., according to a study published in the journal Cell Stem Cell. — Reuters. Medtronic has filed for premarket approval for an artificial pancreas that, if approved … |
WTNH Connecticut News (press release) |
Cured blind man, U.S. senator crusade on Capitol Hill for stem cell innovations
WTNH Connecticut News (press release) Doug Oliver’s surgeon extracted marrow from his hip bone and injected the stem cells into his Doug Oliver’s surgeon, Dr. Jeffrey Weiss, extracted marrow from his hip bone and injected the stem cells into his eyes, curing his blindness. (Photo: Doug … |
Daily Mail |
Dolly the sheep may have pushed stem cell research forward 20 years, says expert
Daily Mail Stem cell research might be 20 years behind where it is today if Dolly the Sheep had never been born, according to the scientist whose team created the world’s first mammal cloned from an adult cell. Speaking on the eve of Dolly’s 20th anniversary … Dolly triggered stem cell researchYahoo7 News Dolly the Sheep creator Sir Ian Wilmut says ‘Noah’s Ark’ of cloned stem cells could halt extinctionsThe National 20 Years after Dolly the Sheep Led the Way—Where Is Cloning Now?Scientific American STAT –NEWS.com.au –Japan Today all 48 news articles » |